Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 25, 2023

BUY
$8.63 - $12.53 $219,202 - $318,262
25,400 Added 173.97%
40,000 $430,000
Q1 2022

Apr 28, 2022

BUY
$11.38 - $21.88 $14,794 - $28,444
1,300 Added 9.77%
14,600 $210,000
Q4 2021

Feb 02, 2022

BUY
$19.66 - $28.11 $7,864 - $11,244
400 Added 3.1%
13,300 $275,000
Q4 2020

Mar 12, 2021

BUY
$23.42 - $39.5 $302,118 - $509,550
12,900 New
12,900 $440,000

Others Institutions Holding RPTX

About Repare Therapeutics Inc.


  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $55.4M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track Deka Bank Deutsche Girozentrale Portfolio

Follow Deka Bank Deutsche Girozentrale and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deka Bank Deutsche Girozentrale, based on Form 13F filings with the SEC.

News

Stay updated on Deka Bank Deutsche Girozentrale with notifications on news.